Cargando…
In silico studies on structural inhibition of SARS-CoV-2 main protease M(pro) by major secondary metabolites of Andrographis paniculata and Cinchona officinalis
The COVID-19 infection by Novel Corona Virus (SARS-CoV-2) has become one of the largest pandemic diseases, with cumulative confirmed infections of 275,233,892 and 5,364,996 deaths to date according to World Health Organization. Due to the absence of any approved antiviral drug to treat COVID-19, its...
Autores principales: | Majumdar, Moumita, Singh, Vishal, Misra, Tarun Kumar, Roy, Dijendra Nath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883239/ https://www.ncbi.nlm.nih.gov/pubmed/35250036 http://dx.doi.org/10.1007/s11756-022-01012-y |
Ejemplares similares
-
Multi-Target β-Protease Inhibitors from Andrographis paniculata: In Silico and In Vitro Studies
por: Panche, Archana N, et al.
Publicado: (2019) -
The coronavirus disease 2019 main protease inhibitor from Andrographis paniculata (Burm. f) Ness
por: Sukardiman,, et al.
Publicado: (2020) -
In silico screening of Andrographis paniculata secondary metabolites as anti-diabetes mellitus through PDE9 inhibition
por: Ischak, Netty Ino, et al.
Publicado: (2022) -
Cinchona Officinalis; Provings
por: Fincke, B.
Publicado: (1883) -
Is Andrographis paniculata extract and andrographolide anaphylactic?
por: Richard, Edwin Jothie, et al.
Publicado: (2017)